MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Life Sciences, Medical Devices & Health Information Technology
2025: Top 10 U.S. Biopharma Clusters 2025
New Jersey
*Industry: New Jersey
PDS Biotechnology Corporation (NASDAQ:PDSB)*
Organization & Developments: PDS Biotechnology
Parents
PDS Biotechnology Corporation (NASDAQ:PDSB)*
Children
*Developing product candidates off its proprietary Versamune platform which 'trains' the immune system to unleash a powerful and targeted T-cell attacks
*Focused on developing multifunctional cancer immunotherapies.
*PDS Biotechnology Corporation is a company dedicated to its cationic, lipid-based Versamune nanoparticle platform technology to treat cancer.
*Pursuing treatments of various cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, and anal cancer
2022: PDS Biotech: Strong Data Indicate Further Upside_seekingalpha.com
2022: PDS Biotechnology Granted FDA Fast Track Designation for Lead Candidate PDS0101
2022: PDS Biotechnology: Better Than A 3 Buck Dart Throw_seekingalpha.com
2022: PDS Biotechnology: Speculative Biotech Worth Buying After Latest Data_seekingalpha.com
2023: PDS Biotechnology: Good Data, But I Am A Little Perplexed By Their Finances_ seekingalpha.com
2023: PDS Biotechnology: Late-Stage Biotech With Enormous Potential_seekingalpha.com
2023: PDS Biotechnology: PDS0101 Being Put To The Test (NASDAQ:PDSB)
2024: PDS Biotechnology: Advancement Of PDS0101 Continues With Expansion Data
2024: PDS Biotechnology: Continuing The Holding Pattern_ seekingalpha.com
2024: PDS Biotechnology: Promising Phase 2 With Cash Issues That Might Be Worth The Risk_ seekingalpha.com
Jumps
Finance & Acquisitions: PDS Biotechnology
Key People: PDS Biotechnology